Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Free Cash Flow: 2019-2025

Historic Free Cash Flow for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to -$8.2 million.

  • Benitec Biopharma's Free Cash Flow fell 149.77% to -$8.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$23.6 million, marking a year-over-year decrease of 21.66%. This contributed to the annual value of -$23.6 million for FY2025, which is 20.61% down from last year.
  • Latest data reveals that Benitec Biopharma reported Free Cash Flow of -$8.2 million as of Q2 2025, which was down 166.01% from -$3.1 million recorded in Q1 2025.
  • In the past 5 years, Benitec Biopharma's Free Cash Flow registered a high of -$2.0 million during Q1 2021, and its lowest value of -$8.2 million during Q2 2025.
  • In the last 3 years, Benitec Biopharma's Free Cash Flow had a median value of -$4.6 million in 2024 and averaged -$5.1 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first slumped by 162.03% in 2021, then soared by 49.87% in 2025.
  • Over the past 5 years, Benitec Biopharma's Free Cash Flow (Quarterly) stood at -$3.3 million in 2021, then tumbled by 76.25% to -$5.9 million in 2022, then climbed by 8.76% to -$5.3 million in 2023, then plummeted by 43.93% to -$7.7 million in 2024, then tumbled by 149.77% to -$8.2 million in 2025.
  • Its Free Cash Flow stands at -$8.2 million for Q2 2025, versus -$3.1 million for Q1 2025 and -$7.7 million for Q4 2024.